Parkinson Disease
UCB announces the U.S. Launch of Neupro (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Published in Health Business Week, August 3rd, 2007
UCB and SCHWARZ PHARMA announced today that Neupro(R) (Rotigotine Transdermal System), a new once-daily transdermal dopamine agonist approved for the treatment of the signs and symptoms of early-stage idiopathic Parkinson's disease, is now commercially available in retail pharmacies throughout the United States. Neupro(R) will be co-promoted by UCB and SCHWARZ PHARMA. These companies have dedicated sales forces that will immediately begin reaching out to physicians who treat Parkinson's disease nationwide.
In conjunction with the U.S. launch, the companies are also kicking off PDAware, a public education campaign which aims to raise the profile of Parkinson's disease....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-08-03)
More Articles from Health Business Week
- Aarp
AARP Calls on President to Release Emergency Funding After Heat Wave Sweeps the Country - Aarp
Divided We Fail: It's Time to Hear about Health and Financial Security in Presidential Debates - Aarp
Status: - Aarp Illinois
Health Care Reform Top Concern for Illinois Voters - Abqaurp
ABQAURP Announces Quality Evaluation Process Conference - Abraxis BioScience, Inc.
Abraxis BioScience and Biocon Limited Announce Licensing Agreement for G-CSF in North America and the European Union - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
